Skip to main content
Top
Published in: Indian Journal of Gastroenterology 2/2011

01-03-2011 | Letter

High prevalence of cholelithiasis in primary hyperparathyroidism: a retrospective analysis of 120 cases

Authors: Sanjay Kumar Bhadada, Anil Bhansali, Viral N. Shah, A. Behera, M. Ravikiran, R. Santosh

Published in: Indian Journal of Gastroenterology | Issue 2/2011

Login to get access

Excerpt

Primary hyperparathyroidism (PHPT) due to parathyroid adenoma is the most common cause of hypercalcemia, which is characterized by high parathyroid hormone (PTH) level despite elevated serum calcium levels [1]. With the advent of autoanalyzer and serum calcium is a part of routine screening in West. The presentation of PHPT is asymptomatic and hence, attention has been diverted to the features like hypertension, mental changes, peptic ulcer disease and gallstone disease [2, 3]. Few studies have shown the association of cholelithiasis with PHPT [4, 5]. Hypercalcemia and elevated PTH have been implicated as a cause for cholelithiasis in patients with PHPT. …
Literature
1.
go back to reference Weber CJ, Sewell CW, McGarity WC. Persistent and recurrent sporadic primary hyperparathyroidism: histopathology, complications, and results of reoperation. Surgery. 1994;116:991–8.PubMed Weber CJ, Sewell CW, McGarity WC. Persistent and recurrent sporadic primary hyperparathyroidism: histopathology, complications, and results of reoperation. Surgery. 1994;116:991–8.PubMed
2.
go back to reference Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet. 1980;1:1317–20.PubMedCrossRef Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet. 1980;1:1317–20.PubMedCrossRef
3.
go back to reference Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341:1249–55.PubMedCrossRef Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341:1249–55.PubMedCrossRef
4.
go back to reference Werner S, Hjern B, Sjöberg HE. Primary hyperparathyroidism. Analysis of findings in a series of 129 patients. Acta Chir Scand. 1974;140:618–25.PubMed Werner S, Hjern B, Sjöberg HE. Primary hyperparathyroidism. Analysis of findings in a series of 129 patients. Acta Chir Scand. 1974;140:618–25.PubMed
5.
go back to reference Amann R. Cholelithiasis in primary hyperparathyroidism. Therapiewoche. 1978;28:657–9. Amann R. Cholelithiasis in primary hyperparathyroidism. Therapiewoche. 1978;28:657–9.
6.
go back to reference Singh V, Trikha B, Nain C, Singh K, Bose S. Epidemiology of gallstone disease in Chandigarh: a community-based study. J Gastroenterol Hepatol. 2001;16:560–3.PubMedCrossRef Singh V, Trikha B, Nain C, Singh K, Bose S. Epidemiology of gallstone disease in Chandigarh: a community-based study. J Gastroenterol Hepatol. 2001;16:560–3.PubMedCrossRef
7.
go back to reference Malhotra SL. Epidemiological study of cholelithiasis among railroad workers in India with special reference to causation. Gut. 1968;9:290–5.PubMedCrossRef Malhotra SL. Epidemiological study of cholelithiasis among railroad workers in India with special reference to causation. Gut. 1968;9:290–5.PubMedCrossRef
8.
go back to reference Broulik PD, Haas T, Adámek S. Analysis of 645 patients with primary hyperparathyroidism with special reference to cholelithiasis. Intern Med. 2005;44:917–21.PubMedCrossRef Broulik PD, Haas T, Adámek S. Analysis of 645 patients with primary hyperparathyroidism with special reference to cholelithiasis. Intern Med. 2005;44:917–21.PubMedCrossRef
9.
go back to reference Ahrendt SA, Ahrendt GM, Pitt HA, Moore EW, Lillemoe KD. Hypercalcemia decrease bile flow and increase billiary calcium in the prairie dog. Surgery. 1995;117:435–42.PubMedCrossRef Ahrendt SA, Ahrendt GM, Pitt HA, Moore EW, Lillemoe KD. Hypercalcemia decrease bile flow and increase billiary calcium in the prairie dog. Surgery. 1995;117:435–42.PubMedCrossRef
10.
go back to reference Mok LL, Nickols GA, Thompson JC, Cooper CW. Parathyroid hormone as a smooth muscle relaxant. Endocrinol Rev. 1989;10:420–36.CrossRef Mok LL, Nickols GA, Thompson JC, Cooper CW. Parathyroid hormone as a smooth muscle relaxant. Endocrinol Rev. 1989;10:420–36.CrossRef
Metadata
Title
High prevalence of cholelithiasis in primary hyperparathyroidism: a retrospective analysis of 120 cases
Authors
Sanjay Kumar Bhadada
Anil Bhansali
Viral N. Shah
A. Behera
M. Ravikiran
R. Santosh
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Indian Journal of Gastroenterology / Issue 2/2011
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-011-0101-0

Other articles of this Issue 2/2011

Indian Journal of Gastroenterology 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.